(Q39397658)

11 September 2017

Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products (English)

1 reference

11 September 2017

0 references

Rehmannia glutinosa

1 reference

Gui-Hyun Baek

1

1 reference

11 September 2017

Yong-Suk Jang

2

1 reference

11 September 2017

Seung-Il Jeong

3

1 reference

11 September 2017

Jaeho Cha

4

1 reference

11 September 2017

Myungsoo Joo

5

1 reference

11 September 2017

Sang-Woo Shin

6

1 reference

11 September 2017

Ki-Tae Ha

7

1 reference

11 September 2017

Han-Sol Jeong

8

1 reference

11 September 2017

1 August 2012

1 reference

11 September 2017

1 reference

11 September 2017

35

1 reference

11 September 2017

4

1 reference

11 September 2017

1232-1241

1 reference

https://scigraph.springernature.com/pub.10.1007/s10753-012-9433-x

11 September 2017

0 references

cites work

Advanced glycation endproducts--role in pathology of diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Role of advanced glycation end products and their receptors in development of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Diabetes and advanced glycoxidation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Rehmannia glutinose ameliorates renal function in the ischemia/reperfusion-induced acute renal failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Rel/NF-kappa B and I kappa B proteins: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

RAGE: a novel cellular receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Characterization of the anti-diabetic and antioxidant effects of rehmannia glutinosa in streptozotocin-induced diabetic Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

A novel strategy to rapidly explore potential chemical markers for the discrimination between raw and processed Radix Rehmanniae by UHPLC-TOFMS with multivariate statistical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Protective effects of catalpol against H2O2-induced oxidative stress in astrocytes primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9433-X

Methylglyoxal and advanced glycation endproducts: new therapeutic horizons?

21 January 2018

1 reference

12 December 2020

Studies on rehmanniae radix. I. Effect of 50% ethanolic extract from steamed and dried rehmanniae radix on hemorheology in arthritic and thrombosic rats

1 reference

12 December 2020

Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation

1 reference

12 December 2020

Antidiabetic effect of seishin-kanro-to in KK-Ay mice

1 reference

12 December 2020

Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes.

1 reference

12 December 2020

Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes

1 reference

12 December 2020

Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus

1 reference

12 December 2020

Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications

1 reference

12 December 2020

Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats

1 reference

12 December 2020

Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

1 reference

12 December 2020

Effects of rehmanniae radix water extract on renal function and renin secretion rate in unanesthetized rabbits

1 reference

12 December 2020

Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy

1 reference

12 December 2020

Effect of Rehmannia glutinosa Libosch water extraction on gene expression of proinsulin in type 2 diabetes mellitus rats

1 reference

12 December 2020

Hypoglycemic activity of polysaccharide fraction from rhizome of Rehmannia glutinosa Libosch. f. hueichingensis Hsiao and the effect on carbohydrate metabolism in normal mouse liver

1 reference

12 December 2020

Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion

1 reference

12 December 2020

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

1 reference

12 December 2020

Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase

1 reference

12 December 2020

10.1007/S10753-012-9433-X

Identifiers

DOI

1 reference

11 September 2017

1 reference